|
⚲
|
| Keyboard |
| Dellora Investments LP
✚
|
|
|---|---|
| CRD # | 310885 |
| SEC # | 801-134957 |
| CIK # | 0001943462 |
| AUM | 148.4 M (2026-03-26) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 203-632-6341 |
| Address | 283 Greenwich Avenue Greenwich, CT 06830 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
Item 5 - Fees and Compensation Fees with respect to the Funds Dellora’s compensation is negotiable and varies, but typically, it charges an annual fee of 1.5% - 1.75% (0.3750% - 0.4375% per quarter) of assets under management, depending on investor share class, which amount is payable in quarterly installments at the beginning or end (depending on the provisions of each client’s partnership or other account agreement) of each calendar quarter based on the net market value of each client’s account on the date the fee accrues and becomes payable. Dellora also typically is allocated from each limited partner in the Funds an incentive allocation generally equal to 15%-20%, depending on investor share class. Incentive allocations for the Long Only Fund are subject to an outperformance amount with respect to each incentive allocation period. Dellora complies with Rule 205-3 under the Investment Advisers Act of 1940, to the extent required by applicable law. Dellora deducts management fees, performance allocations and fees directly from client accounts but may bill a client for such amounts on request. Fees with respect to the SMA Fees are negotiable, but generally, Dellora will charge an annual fee of 1.5% (0.375% per quarter) of the account balance. Dellora is also entitled to receive an annual incentive fee equal to the incentive allocation percentage multiplied by the applicable income. The incentive allocation percentage is 15%. The applicable income is the positive amount equal to the balance of the account minus the high watermark. A limited partner may generally withdraw all or any portion of the balance in its capital account as of the last day of the calendar quarter immediately following the twelve-month period after the date that the capital account was established and the last day of each calendar quarter thereafter. Requests for withdrawal must be in writing at least sixty (60) calendar days prior to the request withdrawal date. In the case of an SMA Client, except as may be otherwise negotiated in particular cases, the holder of an individually managed account may terminate the account by giving 30 days’ prior written notice after the lock-up period of eight (8) full calendar quarters. The capital account of an investor admitted to the Funds other than on the first calendar day of a calendar quarter will be subject to a pro rata portion of the management fee charged for such quarter based upon the portion of the quarter for which it is an investor. No portion of the management fee will be refunded if an investor is permitted to withdraw on a date other than the end of a calendar quarter. Each account is responsible for its own costs and expenses related to investments and operations, including trading costs and expenses (such as brokerage commissions, expenses related to short sales, and clearing and settlement charges), and research related expenses. Each Fund is responsible for its own ongoing legal and regulatory filings, administrative, valuation, auditing and accounting, entity-level taxes, insurance, and, bookkeeping fees and expenses, and the fees and expenses charged by any fund administrator for its accounting, bookkeeping and other services. Dellora bears its own operating, general, administrative and overhead costs and expenses, other than the expenses described above. All or part of these costs and expenses may be paid, however, by securities brokerage firms and futures commission merchants that execute clients’ securities trades, as discussed in Item 12 – Brokerage Practices below. Dellora and its supervised persons do not receive a brokerage commission or any other compensation attributable to the sale of securities or investment products. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
Item 7 - Types of Clients Dellora’s Clients (and Investors therein) may include endowments, sovereign wealth funds, public or private pensions, foundations, institutions, and the Fund. Dellora does not provide investment advice individually to the Investors of the Fund. Interests in the Funds are offered pursuant to applicable exemptions from registration under the Securities Act and the 1940 Act. Permitted Investors in the Funds may include high net worth individuals, banks, thrift institutions, pension and profit-sharing plans, trusts, estates, charitable organizations and other business entities. The minimum investment requirement for the Funds is $1,000,000. However, the General Partners of the Funds, in its sole discretion, may permit investments that are less than the required minimum investment requirement. In addition, legal eligibility requirements must be met to invest in the Funds. Minimum account sizes for separate other Client accounts vary depending on the type of investment advisory services to be performed and in certain circumstances may be negotiable. Separate Client account investment advisory services are generally available to individuals and institutional accounts with a minimum account at the discretion of the Investment Manager. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Dellora Long Only Master Fund LP | [2025-01-20] | 0.4 M | 12.6 M |
| Filed 2026-03-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Dellora Investments Master Fund LP | [2023-01-27] | 49.9 M | 110.7 M |
| Filed 2026-03-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 123.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 25.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 148.4 |
| By Discretionary | ||
| Discretionary | 6 | 148.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 148.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 84.1 | |
| United States Persons | 64.3 | |
| Total | 6 | 148.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Kevin Pyun | Executive Officer | 5 | 2 | |
| Dellora Investments Fund GP LLC | Executive Officer | 2 | 2 | |
| Dellora Long Only Fund GP LLC | Promoter | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001943462] | |
| 4 | [0001943462] | |
| SC 13G | [0001943462] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Dellora Investments LP | Tenax Therapeutics Inc | [2024-12-05] |
| Dellora Investments LP | Pieris Pharmaceuticals Inc | [2024-08-07] |
| Dellora Investments LP | Cyclacel Pharmaceuticals Inc | [2022-08-22] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 9845003F49A0D1062A93 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tenax Therapeutics Inc | |
| Dellora Investments LP | |
| Palvella Therapeutics Inc |
| Comparable Firms | State | AUM |
|---|---|---|
|
Veteri Place Corporation
✚
|
NJ | 150.7 M |
|
Miura Global Management LLC
✚
|
150.2 M | |
|
Felis Advantage LP
✚
|
MA | 150.0 M |
|
Konektis Capital Management LP
✚
|
NY | 149.8 M |
|
Chamonix Partners Capital Management LLC
✚
|
NY | 149.2 M |
|
VIS Advisors LP
✚
|
NY | 148.8 M |
|
Column Park Asset Management LP
✚
|
FL | 148.8 M |
|
AWH Capital LP
✚
|
TX | 147.6 M |
|
Scalebuilder LLC
✚
|
NY | 145.8 M |
|
True Partner Capital USA Holding Inc
✚
|
IL | 145.6 M |